These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31433509)

  • 1. Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
    Wu T; Zhao J; Liu Z; Shen P; Zhang M; Sun G; Liu J; Liao B; Chen J; Zhu S; Dai J; Wang Z; Zhang H; Zhao P; Zhang X; Zhu X; Ni Y; Chen N; Zeng H
    Prostate; 2019 Oct; 79(14):1673-1682. PubMed ID: 31433509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of perineural invasion in patients with de novo metastatic prostate cancer.
    Zhao J; Chen J; Zhang M; Tang X; Sun G; Zhu S; Liu J; Zhang H; Zhang X; Yin X; Zhao P; Zhu X; Ni Y; Dai J; Shen P; Chen N; Zeng H
    Andrology; 2019 Mar; 7(2):184-192. PubMed ID: 30609313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The subgroup analysis of the prognostic value of the intraductal carcinoma of the prostate in patients with metastatic prostate cancer].
    Zhao JG; Nie L; Chen XQ; Chen N; Zeng H
    Zhonghua Wai Ke Za Zhi; 2019 Jun; 57(6):422-427. PubMed ID: 31142066
    [No Abstract]   [Full Text] [Related]  

  • 4. The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer.
    Zhao J; Liu J; Sun G; Zhang M; Chen J; Shen P; Liu Z; Liao B; Zhang X; Gong J; Chen N; Zeng H;
    J Urol; 2019 Apr; 201(4):759-768. PubMed ID: 30652989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?
    Zhao T; Liao B; Yao J; Liu J; Huang R; Shen P; Peng Z; Gui H; Chen X; Zhang P; Zhu Y; Li X; Wei Q; Zhou Q; Zeng H; Chen N
    Prostate; 2015 Feb; 75(3):225-32. PubMed ID: 25307858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.
    Knipper S; Preisser F; Mazzone E; Mistretta FA; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Jun; 17(3):231-237.e2. PubMed ID: 31080021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.
    Culp SH; Schellhammer PF; Williams MB
    Eur Urol; 2014 Jun; 65(6):1058-66. PubMed ID: 24290503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study.
    Bandini M; Pompe RS; Marchioni M; Zaffuto E; Gandaglia G; Fossati N; Cindolo L; Montorsi F; Briganti A; Saad F; Karakiewicz PI
    Int Urol Nephrol; 2018 Jan; 50(1):71-78. PubMed ID: 29129028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
    Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
    Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study.
    Yao J; Liu Y; Liang X; Shao J; Zhang Y; Yang J; Zheng M
    Front Endocrinol (Lausanne); 2021; 12():778758. PubMed ID: 34956090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate.
    Yamamoto A; Kato M; Matsui H; Ishida R; Kimura T; Funahashi Y; Sassa N; Matsukawa Y; Kamihira O; Hattori R; Gotoh M; Tsuzuki T
    Int J Clin Oncol; 2018 Jun; 23(3):584-590. PubMed ID: 29397469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of Gleason scores in metastatic prostate cancer.
    Rusthoven CG; Carlson JA; Waxweiler TV; Yeh N; Raben D; Flaig TW; Kavanagh BD
    Urol Oncol; 2014 Jul; 32(5):707-13. PubMed ID: 24629494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).
    Francini E; Gray KP; Xie W; Shaw GK; Valença L; Bernard B; Albiges L; Harshman LC; Kantoff PW; Taplin ME; Sweeney CJ
    Prostate; 2018 Sep; 78(12):889-895. PubMed ID: 29707790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world progression in the survival of de novo Metastatic prostate cancer over the past decade.
    Guo X; Xia H; Zhang F; Hao G
    Urol Oncol; 2024 Mar; 42(3):68.e1-68.e9. PubMed ID: 38097476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Therapy Improves Survival in Metastatic Prostate Cancer.
    Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
    Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local treatment Associated With Prognosis among Men With Metastatic Prostate Cancer: A SEER-Based Study.
    Zhou J; Cao Y; Chen H; Wu Y; Ding J; Qi J
    Clin Genitourin Cancer; 2023 Jun; 21(3):e204-e215. PubMed ID: 36858922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer.
    Koo KC; Park SU; Kim KH; Rha KH; Hong SJ; Yang SC; Chung BH
    Yonsei Med J; 2015 Sep; 56(5):1206-12. PubMed ID: 26256961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of time to metastasis on overall survival in patients with prostate cancer.
    Frees S; Akamatsu S; Bidnur S; Khalaf D; Chavez-Munoz C; Struss W; Eigl BJ; Gleave M; Chi KN; So A
    World J Urol; 2018 Jul; 36(7):1039-1046. PubMed ID: 29488095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
    Kim A; Kwon T; You D; Jeong IG; Go H; Cho YM; Hong JH; Ahn H; Kim CS
    J Korean Med Sci; 2015 Apr; 30(4):385-9. PubMed ID: 25829805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.